£62.00

It has never been this cheap. We have no record of a lower price.

£62 today · cheaper than every other day in the last 3 months

CD34-Antigen und das Stroma des Gebärmutterhalses: Eine klinisch-pathologische Studie zur Rolle der CD34-Antigenexpression bei prämalignen und malignen Läsionen des Gebärmutterhalses

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 42 days · 42 data points (no recent data)

Historical
Generating forecast…
£62.00 £58.90 £60.14 £61.38 £62.62 £63.86 £65.10 25 July 2026 04 August 2026 14 August 2026 24 August 2026 04 September 2026
View at Amazon ↗

Price data last checked 49 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 42 days • 1 price levels

Days at Price
42 days 0 11 21 32 42 £62 Days at Price

Price Analysis

Most common price: £62 (42 days, 100.0%)

Price range: £62 - £62

Price levels: 1 different prices over 42 days

Description

Gebärmutterhalskrebs ist weltweit die am vierthäufigsten diagnostizierte Krebsart bei Frauen. Bei indischen Frauen ist er die zweithäufigste Krebsart. Der Schwerpunkt dieses Buches liegt auf der Expression des CD34-Antigens im Stroma von prämalignen und malignen Läsionen des Gebärmutterhalses. Ziel des Buches ist es, festzustellen, ob der Verlust von CD34 spezifisch für invasive Erkrankungen des Gebärmutterhalses ist, und auch die prognostische Bedeutung der CD34-Expression beim Gebärmutterhalskrebs zu bewerten, wo immer dies möglich ist. Darüber hinaus wurde auch die Rolle von CD34 als Marker für die Angiogenese bei Gebärmutterhalskrebs untersucht. Darüber hinaus wurde ein kurzer Überblick über die Literatur, die klinische Korrelation und die verwendete Methodik gegeben. Die Mikrofotografien von Gebärmutterhalsläsionen wurden aus unserem täglichen Diagnosematerial ausgewählt. Dieses Buch ist für alle Pathologen gedacht, um sie bei ihrer diagnostischen Routinearbeit zu unterstützen.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
25 July 2023
Listed Since
26 July 2023

Barcode

No barcode data available

Similar Products You Might Like

L'antigène CD34 et le stroma du col de l'utérus: Étude clinicopathologique du rôle de l'expression de l'antigène CD34 dans les lésions précancéreuses et malignes du col de l'utérus
98% match

L'antigène CD34 et le stroma du col de l'utérus: Étude clinicopathologique du rôle de l'expression de l'antigène CD34 dans les lésions précancéreuses et malignes du col de l'utérus

£62.00 04 Sep 2026
Prévention du cancer du col de l’utérus: Intérêts des analyses morphologiques, immunohistochimiques et moléculaires (Omn.Univ.Europ.)
96% match

Prévention du cancer du col de l’utérus: Intérêts des analyses morphologiques, immunohistochimiques et moléculaires (Omn.Univ.Europ.)

ÉDITIONS UNIVERSITAIRES EUROPÉENNES

£50.00 18 Sep 2026
Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)
96% match

Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)

Springer

£94.68 24 Sep 2026
Topics on Cervical Cancer With an Advocacy for Prevention
95% match

Topics on Cervical Cancer With an Advocacy for Prevention

IntechOpen

£119.00 01 Oct 2026
Modern Approach to Colposcopic Findings: Atlas for the Practitioner in Gynaecology
95% match

Modern Approach to Colposcopic Findings: Atlas for the Practitioner in Gynaecology

De Gruyter

£123.50 19 Sep 2026
High-Risk Human Papillomavirus and Cervical Carcinoma: A Study on Human Papillomavirus: High-Risk E6, p53 and p16 Proteins Expression and Their Role in Cervical Carcinogenesis
95% match

High-Risk Human Papillomavirus and Cervical Carcinoma: A Study on Human Papillomavirus: High-Risk E6, p53 and p16 Proteins Expression and Their Role in Cervical Carcinogenesis

LAP Lambert Academic Publishing

£48.00 27 Sep 2026
Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer: From Molecular Insights to Precision Solutions (Volume 21) (Cancer Sensitizing Agents for Chemotherapy, Volume 21)
95% match

Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer: From Molecular Insights to Precision Solutions (Volume 21) (Cancer Sensitizing Agents for Chemotherapy, Volume 21)

Elsevier

£124.00 03 Oct 2026
What Every Woman Should Know about Cervical Cancer: Revised and Updated
95% match

What Every Woman Should Know about Cervical Cancer: Revised and Updated

Springer

£107.47 18 Sep 2026
Open, Laparoscopic, and Robotic Surgery for Cervical Cancer
95% match

Open, Laparoscopic, and Robotic Surgery for Cervical Cancer

Springer

£80.67 18 Sep 2026
Cervical Cancer: Recent Advances and New Perspectives
95% match

Cervical Cancer: Recent Advances and New Perspectives

IntechOpen

£95.00 22 Sep 2026
Cellular Pathology of Glandular Lesions and Uncommon Neoplasms of the Cervix
95% match

Cellular Pathology of Glandular Lesions and Uncommon Neoplasms of the Cervix

Springer

£80.67 02 Oct 2026
Cytology and Colposcopy in Gynecological Practice
95% match

Cytology and Colposcopy in Gynecological Practice

Jaypee Brothers Medical Publishers

£78.01 30 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in the United States
95% match

The 2023-2028 Outlook for Cervical Cancer Treatments in the United States

£520.00 25 Aug 2026
GYNECOLOGIC AND OBSTETRIC PATHOLOGY: Molecular Insights and Diagnostic Criteria for Uterine, Ovarian & Cervical Neoplasms.
95% match

GYNECOLOGIC AND OBSTETRIC PATHOLOGY: Molecular Insights and Diagnostic Criteria for Uterine, Ovarian & Cervical Neoplasms.

Price unavailable
The Resistance of Cervical Cancer to Chemotherapy and its Reversal (Volume 9) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 9)
95% match

The Resistance of Cervical Cancer to Chemotherapy and its Reversal (Volume 9) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 9)

Elsevier

£125.15 19 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States
95% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States

£520.00 02 Oct 2026
Kolposkopie in der Praxis: Lehrbuch und Atlas
95% match

Kolposkopie in der Praxis: Lehrbuch und Atlas

Springer

£99.73 19 Sep 2026
Cervical Cancer: A Global Public Health Treatise
95% match

Cervical Cancer: A Global Public Health Treatise

IntechOpen

£119.00 25 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India
95% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India

£515.00 03 Oct 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in India
95% match

The 2023-2028 Outlook for Cervical Cancer Treatments in India

£515.00 23 Aug 2026
The 2023-2028 World Outlook for Cervical Cancer Treatments
95% match

The 2023-2028 World Outlook for Cervical Cancer Treatments

£795.00 27 Aug 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in China
95% match

The 2023-2028 Outlook for Cervical Cancer Treatments in China

£495.00 23 Aug 2026
Cancer of the Uterine Endometrium - Advances and Controversies
95% match

Cancer of the Uterine Endometrium - Advances and Controversies

IntechOpen

£119.00 22 Sep 2026
Preventive screening for cervical cancer among low-income patients: Use of Pap smear screening among low-income patients
95% match

Preventive screening for cervical cancer among low-income patients: Use of Pap smear screening among low-income patients

LAP Lambert Academic Publishing

£57.00 07 Oct 2026